RMD, a Dynasil Company

RMD, a Dynasil Company is a leading expert in the fields of radiation detection, high-speed imaging, nuclear instrumentation, and NDT. Since its establishment in 1974, RMD has been dedicated to conducting top-notch research and developing cutting-edge commercial products. With over 70 awarded U.S. patents, the company's research and products are widely utilized in various scientific disciplines, including space science, particle physics, nuclear security, clinical diagnoses, and environmental research.

RMD has established itself as a go-to partner for governments, corporations, and research institutes seeking advancements in radiation detection and imaging. The company's research partnerships offer an efficient and cost-effective solution for those looking to leverage RMD's expertise in product commercialization. Recognized for its outstanding contributions, RMD received the National Tibbett’s Award in 2002 and 2012.

Furthermore, RMD is focused on commercializing its own research and technologies with an unwavering commitment to process and quality. The company's reputation is expanding as it delves into the reliable commercial production of high-quality scintillators and detectors. Notably, its patented CLLBC dual-mode gamma-neutron scintillators have garnered attention for their cost-saving capabilities and their role in enabling first responders to swiftly and accurately detect a wide range of potential threats.

Recently, RMD secured a $2.20 million grant investment from the US Department of Energy on 20 February 2024, underscoring the confidence and support the company has garnered from renowned entities in its pursuit of advancing innovative technologies in the field of radiation detection and imaging.

As an investor in the healthcare sector, RMD presents a promising opportunity for venture capital firms seeking to support a pioneering company that is at the forefront of transformative solutions for radiation detection and imaging. With its extensive expertise, strong emphasis on research and development, and recognition from governmental and industry bodies, RMD is poised to make a significant impact and continue driving advancements in the healthcare industry.